Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
editorial
. 1983 Jul 15;129(2):110–112.

Preventing the congenital rubella syndrome by vaccinating women at risk.

J H Joncas
PMCID: PMC1875261  PMID: 6861052

Full text

PDF
110

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buser F., Nicolas A., L'Etoile M. Vaccination with RA 27-3 rubella vaccine. Am J Dis Child. 1971 Jul;122(1):53–56. doi: 10.1001/archpedi.1971.02110010089015. [DOI] [PubMed] [Google Scholar]
  2. Chantler J. K., Ford D. K., Tingle A. J. Rubella-associated arthritis: rescue of rubella virus from peripheral blood lymphocytes two years postvaccination. Infect Immun. 1981 Jun;32(3):1274–1280. doi: 10.1128/iai.32.3.1274-1280.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chantler J. K., Tingle A. J. Replication and expression of rubella virus in human lymphocyte populations. J Gen Virol. 1980 Oct;50(2):317–328. doi: 10.1099/0022-1317-50-2-317. [DOI] [PubMed] [Google Scholar]
  4. Coulombe L., Rosser W. W. Can we prevent an increase in the incidence of congenital rubella syndrome in the next decade? Can Med Assoc J. 1981 Jul 1;125(1):37–40. [PMC free article] [PubMed] [Google Scholar]
  5. Deinard A. S., Venters H. D., Bilka P. J., Herrmann K. L., Page A. R. Rubella-antibody titres in rheumatoid arthritis. Lancet. 1974 Mar 30;1(7857):526–528. doi: 10.1016/s0140-6736(74)92713-5. [DOI] [PubMed] [Google Scholar]
  6. Grillner L. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines. J Infect Dis. 1976 Jun;133(6):637–641. doi: 10.1093/infdis/133.6.637. [DOI] [PubMed] [Google Scholar]
  7. Hanissian A. S., Martinez A. J., Jabbour J. T., Duenas D. A. Vasculitis and myositis secondary to rubella vaccination. Arch Neurol. 1973 Mar;28(3):202–204. doi: 10.1001/archneur.1973.00490210082014. [DOI] [PubMed] [Google Scholar]
  8. Hethcote H. W. Measles and rubella in the United States. Am J Epidemiol. 1983 Jan;117(1):2–13. doi: 10.1093/oxfordjournals.aje.a113511. [DOI] [PubMed] [Google Scholar]
  9. Hillary I. B., Griffith A. H. Persistence of antibody 10 years after vaccination with Wistar RA27/3 strain live attenuated rubella vaccine. Br Med J. 1980 Jun 28;280(6231):1580–1581. doi: 10.1136/bmj.280.6231.1580-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hinman A. R., Bart K. J., Orenstein W. A., Preblud S. R. Rational strategy for rubella vaccination. Lancet. 1983 Jan 1;1(8314-5):39–40. doi: 10.1016/s0140-6736(83)91572-6. [DOI] [PubMed] [Google Scholar]
  11. Horstmann D. M., Liebhaber H., Le Bouvier G. L., Rosenberg D. A., Halstead S. B. Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic. N Engl J Med. 1970 Oct 8;283(15):771–778. doi: 10.1056/NEJM197010082831501. [DOI] [PubMed] [Google Scholar]
  12. Johnstone T. Rubella immunization. Can Med Assoc J. 1981 May 15;124(10):1267–1267. [PMC free article] [PubMed] [Google Scholar]
  13. Joncas J. H. Letter: Rubella immunization. Can Med Assoc J. 1974 Nov 2;111(9):907–911. [PMC free article] [PubMed] [Google Scholar]
  14. Lavergne B., Frappier-Davignon L., Chagnon A. Etude de l'immunité à la rubéole chez les adolescentes de la province de québec, 1976-1977. Union Med Can. 1981 Dec;110(12):1056–1059. [PubMed] [Google Scholar]
  15. Lebon P., Lyon G. Letter: Non-congenital rubella encephalitis. Lancet. 1974 Aug 24;2(7878):468–468. doi: 10.1016/s0140-6736(74)91853-4. [DOI] [PubMed] [Google Scholar]
  16. Lerman S. J., Nankervis G. A., Heggie A. D., Gold E. Immunologic response, virus excretion, and joint reactions with rubella vaccine. A study of adolescent girls and young women given live attenuated virus vaccine (HPV-77:DE-5). Ann Intern Med. 1971 Jan;74(1):67–73. doi: 10.7326/0003-4819-74-1-67. [DOI] [PubMed] [Google Scholar]
  17. Middleton P. J., Larke R. P., Lessard P., Doran T. A. Guide to the management of rubella problems. Can Med Assoc J. 1977 Mar 5;116(5):484–488. [PMC free article] [PubMed] [Google Scholar]
  18. Ogra P. L., Chiba Y., Ogra S. S., Dzierba J. L., Herd J. K. Rubella-virus infection in juvenile rheumatoid arthritis. Lancet. 1975 May 24;1(7917):1157–1161. doi: 10.1016/s0140-6736(75)93136-0. [DOI] [PubMed] [Google Scholar]
  19. Ogra P. L., Herd J. K. Arthritis associated with induced rubella infection. J Immunol. 1971 Sep;107(3):810–813. [PubMed] [Google Scholar]
  20. Thompson G. R., Weiss J. J., Shillis J. L., Brackett R. G. Intermittent arthritis following rubella vaccination. A three-year follow-up. Am J Dis Child. 1973 Apr;125(4):526–530. doi: 10.1001/archpedi.1973.04160040040008. [DOI] [PubMed] [Google Scholar]
  21. Tingle A. J., Ford D. K., Price G. E., Kettyls D. W. Prolonged arthritis in identical twins after rubella immunization. Ann Intern Med. 1979 Feb;90(2):203–204. doi: 10.7326/0003-4819-90-2-203. [DOI] [PubMed] [Google Scholar]
  22. Wolinsky J. S., Berg B. O., Maitalnd C. H. Progressive rubella panencephalitis. Arch Neurol. 1976 Oct;33(10):722–723. doi: 10.1001/archneur.1976.00500100056016. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES